In the latest interview with P&T, Dr. David Nash discusses the prospects for bipartisan legislation on reigning in prescription costs; eliminating drug shortages; and opaque hospital charges, along with the latest report from the Pharmacy Quality Alliance on access to care. He also discusses the need for value-based contracting, and his own personal plans vis-à-vis the Jefferson College of Population Health.
You are here
Dr. David Nash reflects on the uncertain implications of the 2018 mid-term elections for healthcare; the promise of precision medicine, telemedicine, and population health; and the financial pressures facing P&T committees, among other topics, in a wide-ranging year-end interview with P&T Editor Sonja Sherritze.
On the 10th anniversary of the Jefferson College of Population Health, Dr. David Nash reflects on the progress of the first college of population health, its influence around the country, and how social determinants still play a major role in patient outcomes and life expectancy.
Dr. David B. Nash, Dean of the Jefferson College of Population Health, talks about the national opioid emergency with Lyn Chesna, Managing Editor of P&T. Dr. Nash describes how population health professionals, big pharma, and nonprofit organizations, such as the 1889 Foundation and the Pharmacy Quality Alliance, are addressing the issue.
In our latest interview, the Dean of the Jefferson College of Population Health tackles a virtual alphabet soup of current events: the GOP versus the ACA, CVS buying Aetna, the role of PBMs, health care’s slice of the GDP, and the hope (and hype) of CAR T.
Dr. David B. Nash, Dean of the Jefferson College of Population Health, talks with P&T Editor Steve McIver about health care reform, value-based treatment, the opioid crisis, telehealth, vaccinations, and our less-than-healthy lifestyles—issues that call for hard work by governments, professions, industry, and every American.
Potential harm stemming from repeal of the Patient Protection and Affordable Care Act worries Dr. David B. Nash, Dean of the Jefferson College of Population Health. In an interview with P&T Editor Steve McIver, Dr. Nash also discusses the future of Medicare, drug pricing, and other key issues facing the health care system.
In a wide-ranging interview, Dr. David B. Nash, Dean of the Jefferson College of Population Health, talks with P&T Editor Steve McIver about value-based pricing, the role of pharmacy benefit managers, Zika virus, antibiotic resistance, and much more.
Dr. David B. Nash, Dean of the Jefferson College of Population Health, talks to P&T’s Steve McIver about the future now that the Supreme Court has again upheld the Patient Protection and Affordable Care Act. He offers insights on cost-control initiatives, using “big data” to help individual patients, and high-profile medical meetings in Philadelphia.
Dr. David Nash, Dean of the Jefferson School of Population Health, talks to P&T editor Sonja Sherritze about the state of healthcare in 2015 as the Supreme Court considers a second challenge to the Patient Protection and Affordable Care Act (ACA) and payers and providers struggle to meet the goals of their accountable care organizations (ACOs).
A leading authority on population health, Dr. David Nash is optimistic about the future of disruptive innovation to improve healthcare in the U.S. The interview was conducted by P&T Editor Sonja Sherritze.
David B. Nash, MD, MBA, the founding dean of the Jefferson School of Population Health at Thomas Jefferson University in Philadelphia, is also a primary care physician. He’s excited about dealing with patients who are more involved in their care. “Give me a patient who’s engaged in her own care any day…. But, you’re going to have to pay me to practice in this new way…. If we don’t change the payment system, we’re never going to change the core of what primary care is about.”
Dr. David Nash discusses the ongoing evolution of the P&T committee at Thomas Jefferson University Hospitals in Philadelphia and the ever-changing role of committee members with Sonja Sherritze, Editor of P&T.